lobbying_activities: 3438860

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3438860	9c86ae0a-f508-482c-8849-37f1dde7db26	Q3	VAN SCOYOC ASSOCIATES	39837	ARUP LABORATORIES, INC.	2025	third_quarter	MED	FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Monitor the following: Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2025-10-17T07:36:48-04:00